Some reports of the compulsory licensing decisions in Thailand.

Financial Times, Thais Warn of Switch to Generic Medicines.

Philip Stevens of the International Policy Network warns of the risk to patients in The Nation.

From the Wall Street Journal, Theft in Thailand.

Relatedly, some headlines from India, which as the WSJ points out is likely to be a source of cheap generics unless/until the Thais can begin production within Thailand:

On the Novartis patent.

And on R&D in India, which is growing, as reported by India Times.